Ace Vision Group Strengthens Executive Team with Addition of Frank Chen as Chief Operating Officer
Ace Vision Group, Inc., an emerging medical device company at the forefront of pioneering a laser microporation therapy for the aging eye, today announced the appointment of Frank Chen as Chief Operating Officer (COO). Mr. Chen brings extensive management to enhance operational efficiencies and drive business growth at Ace Vision Group (AVG).
Explore More Articles
Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) — Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an event and multiple scientific presentations at the 2025 American Society of Cataract and Refractive Surgery (ASCRS) Annual …
read moreLaser scleral microporation improves near vision in emmetropic presbyopes
WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, Robert E. Ang, MD, discusses results from a study of laser scleral microporation.
read moreIs presbyopia the newest specialty?
The presbyopia landscape is crowded today with innovations to treat this condition, including corneal procedures, pharmacologic treatments, scleral procedures, and phakic and intraocular (IOL) lenses, according to Karolinne Maia Rocha, MD, PhD, director of cornea and refractive surgery at the Medical University of South Carolina in Charleston. Corneal proceduresProcedures that are coming down the pike …
read more